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and false positives is thoroughly researched
in order to understand the causes of the
limitations. It is essential that each test is
validated using a range ofchemical structures
which in vivo have different tissue and
species specificities. It is necessary to estab-
lish for each chemical a reproducible dose-
response relationship and to be able to
distinguish between subtle changes likely to
be associated in vivo with tumour develop-
ment and gross effects likely to result in cell
death. Much more effort must be expended
on developing reliable quality control; a
single chemical standard is most unlikely to
be adequate to control the quality of
combined metabolism and response systems.
The future
It is to be hoped that the progressive
development of improved short-term ap-
proaches for detecting and characterizing
carcinogens and related compounds will not
be inhibited by the natural desire to obtain
rapidly a universal short-term test for
screening carcinogens.
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BACTERIAL MUTATION TESTS fall into a
general category of short-term assays for
carcinogen screening which are based on the
unifying hypothesis that carcinogens charac-
teristically react with, modify, induce the
repair of, interrupt the replication of, or
otherwise alter the structure, function or
subsequent fate of DNA; in other words,
most carcinogens have been found to cause
DNA damage. The detection ofDNA damage
has therefore become a major preoccupation
of those interested in determining which, of
those many thousands of chemicals already
in use, or in development, are most likely to
have carcinogenic properties. At present, the
most sensitive, reliable, rapid and universally
applicable methods for detecting DNA
damage are thosebasedonbacterial mutation.
Mutation may be defined as a stable herit-
able change in a DNA nucleotide sequence
which is detected as a phenotypic change.
Such heritable changes may be due to base
substitutions (transitions, transversions)
frame shifts (deletion or addition of one or
few nucleotide pairs) large deletions, inser-
tions or translocations. Few if any mutagens
induce only one type of mutational change,
but instead exhibit a characteristic muta-
tional spectrum which depends on the nature
of the primary DNA alteration (modification
of a base, phosphate or sugar, strand break,
or incorporation of a modified base) and the
secondary effects of the organisms' response
to the DNA alteration, by the operation of
various DNA-repair systems and by replica-
tion of daughter strands upon a modified
template. The same mutagen may therefore
induce different mutational patterns in
organisms of different genetic background.
Mutations may be detected by methods
which assay for forward or reverse mutation.
Forward mutation (e.g. from drug sensitivity
to drug resistance) have the theoretical
advantage ofpresenting a large genetic target
and should therefore detect many of the
DNA alterations mentioned above, including
deletions, all of which may be expressed by
the same phenotype. Reverse mutation
assays (e.g. amino acid auxotrophy to proto-
trophy) use bacteria already mutant at an
easily detected locus, and the test consists of
determining the rate at which the test
chemical induces a second mutation which
abolishes or suppresses the effect of the pre-
existing mutation. The genetic target is
therefore small, selective and specific. SeveralBRITISH ASSOCIATION FOR CANCER RESEARCH 503
indicator bacteria or a single strain with
multiple markers are therefore necessary to
overcome the effects of mutagen specificity.
Since the bacteria used in short-term tests
lack the enzymesystems, presentinmammals,
which are responsible for the metabolism of
xenobiotics to species which are more easily
excreted (and, unfortunately in some cases
converted to highly reactive electrophilic
inetabolites capable of damaging DNA)
tissue extracts must be added to mimic
mammalian metabolism in the chosen assay
system. Such metabolizing systems are, of
course, very crude. Their activity can be
modulated in arbitrary ways by pretreatment
of the donor animals with a variety of com-
pounds which can vary both the level and
nature of the metabolizing systems. Further
variability can be imposed by the choice of
donor species and strain, the age ofthe chosen
animals, and changing the proportion of
tissue extract relative to co-factors, and by
the method used in the assay (e.g. liquid
incubation vs agar overlay).
It is clear, therefore, that there is scope for
enormous variety in bacterial mutation tests,
depending on the choice offorward or reverse
mutation, bacterial species and strain, and
by the nature and activity of the metabolic
system. Taking into account these variables,
it seems very unlikely that a quantitative
relationship between mutagenic potency and
carcinogenic potency would exist for the
generality of known chemical carcinogens
tested in a highly selective assay system; the
gross imperfections of long-term carcino-
genicity tests in animals, especially in sensi-
tivity and (in many cases) in the reporting of
data, are further factors which militate
against the likelihood of useful quantitative
extrapolations between bacterial mutation
data and carcinogenic risk to mammals
including man. Recently published studies
which have addressed this problem directly,
using closely related homologous chemical
series, have failed to demonstrate such a
quantitative relationship.
On the other hand, there is now a plethora
ofinformation, based on numerous large scale
trials, which reinforces the view that bac-
terial mutagenicity tests, if performed with
due regard to the scientific criteria of repro-
ducibility, statistical significance and dose-.
responsiveness, are extremely useful for
determining whether a chemical has qualities
characteristic of carcinogens. Moreover, the
speed and sensitivity of these tests allows
their use in a variety ofroles other than mass-
screening; the analysis of complex mixtures
from biological fluids, excreta, air and water
samples, goods, cosmetics and products from
industrial processes is now quite feasible by
the application of appropriate bacterial
mutation assays.
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LONG-TERM animal carcinogenicity tests
are unable to keep up with the number of
chemicals requiring testing. A variety of
short-term tests have been proposed which
are alleged to be capable of discriminating
between carcinogens and non-carcinogens.
Until the mechanism of cancer induction and
progression is established, short-term tests
to detect carcinogens must be based on
empirical correlations between animal and
human cancer and the end-points ofthe tests.
There are several theories on the cause of
cancer but most are genetically based, since
tumours are due to an irreversible process and
result in new information being passed to
subsequent cell generations. The majority of
short-term tests to detect carcinogens are
based on the idea that the primary event in
chemical carcinogenesis is mutation in soma-
tic cells. While data gleaned from the use of
these tests have provided strong evidence
that many chemical carcinogens are mutagens
and that the initial event in chemical muta-
genesis is an attack on DNA by electrophiles,
there are, nevertheless, some chemicals whose
carcinogenic action cannot be explained in
this way, e.g. promoters, hormonal carcino-
gens and solid-state carcinogens.